November 6, 2019   Focus on DME/DR AI model predicts future DR progression in individual patients Artificial intelligence (AI) and deep learning (DL) can predict which patients with diabetic retinopathy (DR) will progress the fastest based on a single, color-fundus photograph, researchers say. Learn more ADVERTISEMENT   Sustained DRSS improvement with aflibercept Treating DR with anti-VEGF agents is an alternative to panretinal laser. In some studies it has been found that “significantly more eyes with DME” can have a ≥2-step improvement in diabetic retinopathy severity scores than in eyes treated with laser, according to Rishi Singh, MD. Find out